{"id":"https://openalex.org/W3035243246","doi":"https://doi.org/10.2337/db20-1073-p","title":"1073-P: Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Soluble Guanylate Cyclase Stimulator Praliciguat in Patients with Diabetic Kidney Disease","display_name":"1073-P: Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Soluble Guanylate Cyclase Stimulator Praliciguat in Patients with Diabetic Kidney Disease","publication_year":2020,"publication_date":"2020-06-01","ids":{"openalex":"https://openalex.org/W3035243246","doi":"https://doi.org/10.2337/db20-1073-p","mag":"3035243246"},"language":"en","primary_location":{"id":"doi:10.2337/db20-1073-p","doi":"https://doi.org/10.2337/db20-1073-p","is_oa":false,"landing_page_url":"https://doi.org/10.2337/db20-1073-p","pdf_url":null,"source":{"id":"https://openalex.org/S129060628","display_name":"Diabetes","issn_l":"0012-1797","issn":["0012-1797","1939-327X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5045134254","display_name":"John P. Hanrahan","orcid":"https://orcid.org/0000-0002-7095-9490","observed_orcids":["https://orcid.org/0000-0002-7095-9490"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"JOHN P. HANRAHAN","raw_affiliation_strings":["Seattle, WA, Chicago, IL, Cambridge, MA, Princeton, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seattle, WA, Chicago, IL, Cambridge, MA, Princeton, NJ","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032870005","display_name":"Ian H. de Boer","orcid":"https://orcid.org/0000-0003-1571-7592","observed_orcids":["https://orcid.org/0000-0003-1571-7592"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"IAN DE BOER","raw_affiliation_strings":["Seattle, WA, Chicago, IL, Cambridge, MA, Princeton, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seattle, WA, Chicago, IL, Cambridge, MA, Princeton, NJ","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012514694","display_name":"George L. Bakris","orcid":"https://orcid.org/0000-0003-1183-1267","observed_orcids":["https://orcid.org/0000-0003-1183-1267"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"GEORGE BAKRIS","raw_affiliation_strings":["Seattle, WA, Chicago, IL, Cambridge, MA, Princeton, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seattle, WA, Chicago, IL, Cambridge, MA, Princeton, NJ","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108393555","display_name":"Phebe J. Wilson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"PHEBE WILSON","raw_affiliation_strings":["Seattle, WA, Chicago, IL, Cambridge, MA, Princeton, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seattle, WA, Chicago, IL, Cambridge, MA, Princeton, NJ","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041212945","display_name":"JAMES D. WAKEFIELD","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"JAMES D. WAKEFIELD","raw_affiliation_strings":["Seattle, WA, Chicago, IL, Cambridge, MA, Princeton, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seattle, WA, Chicago, IL, Cambridge, MA, Princeton, NJ","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054973235","display_name":"Jelena P. Seferovi\u0107","orcid":"https://orcid.org/0000-0003-3002-2887","observed_orcids":["https://orcid.org/0000-0003-3002-2887","https://orcid.org/0000-0002-3267-6828"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"JELENA P. SEFEROVIC","raw_affiliation_strings":["Seattle, WA, Chicago, IL, Cambridge, MA, Princeton, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seattle, WA, Chicago, IL, Cambridge, MA, Princeton, NJ","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089739039","display_name":"Jennifer G. Chickering","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"JENNIFER CHICKERING","raw_affiliation_strings":["Seattle, WA, Chicago, IL, Cambridge, MA, Princeton, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seattle, WA, Chicago, IL, Cambridge, MA, Princeton, NJ","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055124545","display_name":"Michael D. Cressman","orcid":"https://orcid.org/0000-0002-1396-4365","observed_orcids":["https://orcid.org/0000-0002-1396-4365"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"MICHAEL CRESSMAN","raw_affiliation_strings":["Seattle, WA, Chicago, IL, Cambridge, MA, Princeton, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seattle, WA, Chicago, IL, Cambridge, MA, Princeton, NJ","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111525044","display_name":"Mark G. Currie","orcid":"https://orcid.org/0009-0007-2239-5014","observed_orcids":["https://orcid.org/0009-0007-2239-5014"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"MARK CURRIE","raw_affiliation_strings":["Seattle, WA, Chicago, IL, Cambridge, MA, Princeton, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seattle, WA, Chicago, IL, Cambridge, MA, Princeton, NJ","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110385743","display_name":"G. Todd Milne","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"GEORGE T. MILNE","raw_affiliation_strings":["Seattle, WA, Chicago, IL, Cambridge, MA, Princeton, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seattle, WA, Chicago, IL, Cambridge, MA, Princeton, NJ","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109975511","display_name":"Albert T. Profy","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"ALBERT T. PROFY","raw_affiliation_strings":["Seattle, WA, Chicago, IL, Cambridge, MA, Princeton, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seattle, WA, Chicago, IL, Cambridge, MA, Princeton, NJ","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.157,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.47070454,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"69","issue":"Supplement_1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10684","display_name":"Acute Kidney Injury Research","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/soluble-guanylate-cyclase-stimulator","display_name":"soluble guanylate cyclase stimulator","score":0.9559999704360962},{"id":"https://openalex.org/keywords/diabetic-nephropathy","display_name":"diabetic nephropathy","score":0.9980000257492065},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.890999972820282},{"id":"https://openalex.org/keywords/albuminuria","display_name":"albuminuria","score":0.7580000162124634},{"id":"https://openalex.org/keywords/urine-albumin-creatinine-ratio","display_name":"urine albumin-creatinine ratio","score":0.8880000114440918},{"id":"https://openalex.org/keywords/nitric-oxide-signaling","display_name":"nitric oxide signaling","score":0.9950000047683716},{"id":"https://openalex.org/keywords/proteinuria","display_name":"proteinuria","score":0.6669999957084656},{"id":"https://openalex.org/keywords/blood-pressure","display_name":"blood pressure","score":0.7409999966621399},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.6809999942779541},{"id":"https://openalex.org/keywords/renin-angiotensin-system-inhibitors","display_name":"renin-angiotensin system inhibitors","score":0.718999981880188},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.5180000066757202},{"id":"https://openalex.org/keywords/dose-comparison","display_name":"dose comparison","score":0.42500001192092896},{"id":"https://openalex.org/keywords/renal-protection","display_name":"renal protection","score":0.4490000009536743}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8037428855895996},{"id":"https://openalex.org/C159641895","wikidata":"https://www.wikidata.org/wiki/Q108377937","display_name":"Renal function","level":2,"score":0.5853918790817261},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5847383141517639},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5770822763442993},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5679260492324829},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5404037833213806},{"id":"https://openalex.org/C2778653478","wikidata":"https://www.wikidata.org/wiki/Q1054718","display_name":"Kidney disease","level":2,"score":0.5289008021354675},{"id":"https://openalex.org/C2780306776","wikidata":"https://www.wikidata.org/wiki/Q426660","display_name":"Creatinine","level":2,"score":0.5086777806282043},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.4831511378288269},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4742766320705414},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4502071142196655},{"id":"https://openalex.org/C2777538456","wikidata":"https://www.wikidata.org/wiki/Q311213","display_name":"Glycated hemoglobin","level":4,"score":0.4407922327518463},{"id":"https://openalex.org/C67761136","wikidata":"https://www.wikidata.org/wiki/Q2105849","display_name":"Post-hoc analysis","level":2,"score":0.42925623059272766},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.42138439416885376},{"id":"https://openalex.org/C2779561371","wikidata":"https://www.wikidata.org/wiki/Q570197","display_name":"Proteinuria","level":3,"score":0.41599828004837036},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3996388912200928},{"id":"https://openalex.org/C2780091579","wikidata":"https://www.wikidata.org/wiki/Q9377","display_name":"Kidney","level":2,"score":0.23288893699645996},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.07826179265975952},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.2337/db20-1073-p","doi":"https://doi.org/10.2337/db20-1073-p","is_oa":false,"landing_page_url":"https://doi.org/10.2337/db20-1073-p","pdf_url":null,"source":{"id":"https://openalex.org/S129060628","display_name":"Diabetes","issn_l":"0012-1797","issn":["0012-1797","1939-327X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4396996981","https://openalex.org/W3112831521","https://openalex.org/W4378348677","https://openalex.org/W2995764953","https://openalex.org/W3081978010","https://openalex.org/W4396992811","https://openalex.org/W4213083250","https://openalex.org/W4405233561","https://openalex.org/W7167792632","https://openalex.org/W4321002417"],"abstract_inverted_index":{"Background:":[0],"Impaired":[1],"nitric":[2],"oxide":[3],"(NO)":[4],"signaling":[5,28],"has":[6],"been":[7],"implicated":[8],"in":[9,29,38,54,146,290,298,310],"the":[10,39,48,218,291],"progression":[11],"of":[12,43,52,168,178,308],"diabetic":[13],"kidney":[14],"disease":[15],"(DKD).":[16],"Praliciguat":[17],"(PRL)":[18],"is":[19],"a":[20,210,223],"soluble":[21],"guanylate":[22],"cyclase":[23],"stimulator":[24],"that":[25,216],"augments":[26],"NO":[27],"vitro":[30],"and":[31,34,50,86,120,131,151,172,193,271,301],"reduces":[32],"proteinuria":[33],"fasting":[35],"plasma":[36],"glucose":[37],"ZSF1":[40],"rat":[41],"model":[42,158],"DKD.":[44,311],"Methods:":[45],"We":[46],"evaluated":[47],"safety":[49],"efficacy":[51,139],"PRL":[53,98,102,162,192,234,284,309],"adults":[55],"(25-75":[56],"y)":[57],"with":[58,212,215],"type":[59],"2":[60],"diabetes,":[61],"eGFR":[62],"30-75":[63],"mL/min/1.73":[64],"m2,":[65],"urine":[66],"albumin":[67],"creatinine":[68],"ratio":[69],"(UACR)":[70],"200-5000":[71],"mg/g,":[72],"hemoglobin":[73],"A1c":[74],"(HbA1c)":[75],"<12%,":[76],"systolic":[77,253],"blood":[78],"pressure":[79],"(BP)":[80],"110-160":[81],"mmHg,":[82],"on":[83],"stable":[84],"glucose-lowering":[85],"renin":[87],"angiotensin":[88],"system-inhibition":[89],"therapy.":[90],"Participants":[91],"were":[92,116,134,186,250,280],"randomized":[93],"1:1:1":[94],"to":[95,148,159],"placebo":[96],"(PBO),":[97],"20":[99],"mg,":[100],"or":[101],"40":[103],"mg":[104],"daily":[105],"for":[106,114,190,197,233,243],"12":[107,152,248],"weeks.":[108],"Two":[109],"first":[110],"morning":[111],"void":[112],"specimens":[113],"UACR":[115,147,180,200,231,289],"collected":[117],"at":[118,246],"baseline":[119,144],"weeks":[121,149],"1,":[122],"4,":[123],"8,":[124],"12.":[125],"Adverse":[126],"events,":[127],"24":[128,251,259],"h":[129,252,260],"BP":[130,254],"serum":[132],"chemistry":[133],"also":[135],"assessed.":[136],"The":[137],"primary":[138,292],"endpoint":[140],"was":[141,202,235],"change":[142],"from":[143,217],"(CFB)":[145],"8":[150],"analyzed":[153],"by":[154],"mixed-effect":[155],"repeated":[156],"measures":[157],"compare":[160],"pooled":[161,191],"vs.":[163],"PBO.":[164],"Results:":[165],"A":[166],"total":[167],"156":[169],"participants":[170],"enrolled":[171],"140":[173],"completed":[174],"treatment.":[175],"Model":[176],"estimates":[177],"mean":[179],"CFB":[181,201,232,242],"[90%":[182],"CI]":[183],"[intent-to-treat":[184],"(ITT)]":[185],"-28%":[187],"[-36,":[188],"-18]":[189],"-15%":[194,203],"[-27,":[195],"0]":[196],"PBO;":[198],"PBO-adjusted":[199,230,241],"[-31,":[204],"4]":[205],"(p=0.17).":[206],"Quality":[207],"checks":[208],"identified":[209],"site":[211],"data":[213],"inconsistent":[214],"overall":[219],"study":[220,307],"population.":[221],"In":[222],"post-hoc":[224],"sensitivity":[225],"analysis":[226],"excluding":[227],"this":[228],"site,":[229],"-20%":[236],"[-33,":[237],"5],":[238],"nominal":[239],"p=0.03.":[240],"other":[244],"variables":[245,303],"week":[247],"(ITT)":[249],"-4.2":[255],"mmHg":[256],"[-7.5,":[257],"-0.8],":[258],"heart":[261],"rate":[262],"3.4":[263],"bpm":[264],"[1.6,":[265],"5.2],":[266],"HbA1c":[267],"-0.27%":[268],"[-0.50,":[269],"0.03],":[270],"cholesterol":[272],"10.1":[273],"mg/dL":[274],"[-19.2,":[275],"-1.0].":[276],"Both":[277],"praliciguat":[278],"doses":[279],"well":[281],"tolerated.":[282],"Conclusion:":[283],"did":[285],"not":[286],"significantly":[287],"reduce":[288],"ITT":[293],"analysis,":[294],"but":[295],"positive":[296],"trends":[297],"UACR,":[299],"BP,":[300],"metabolic":[302],"warrant":[304],"further":[305],"clinical":[306],"Disclosure":[312],"J.P.":[313,373],"Hanrahan:":[314],"Employee;":[315,363,375,384,390,403,409],"Self;":[316,324,330,340,353,364,370,376,385,391,395,404,413],"Cyclerion":[317,365,371,377,392,396,405,414,419],"Therapeutics.":[318,366,372,378,393,397],"I.":[319],"de":[320],"Boer:":[321],"Advisory":[322],"Panel;":[323],"Boehringer":[325],"Ingelheim":[326],"International":[327],"GmbH.":[328],"Consultant;":[329,339],"George":[331],"Clinical,":[332],"Goldfinch":[333],"Bio,":[334],"Ironwood":[335,407,416],"Pharmaceuticals.":[336,408,417],"G.":[337],"Bakris:":[338],"Alnylam,":[341],"Merck":[342],"&":[343],"Co.,":[344],"Inc.,":[345,347,358],"Relypsa,":[346],"Teijin":[348],"Pharma":[349],"Limited.":[350],"Other":[351],"Relationship;":[352],"Bayer":[354],"AG,":[355],"Novo":[356],"Nordisk":[357],"Vascular":[359],"Dynamics.":[360],"P.":[361],"Wilson:":[362],"J.D.":[367],"Wakefield:":[368],"Stock/Shareholder;":[369,394,412],"Seferovic:":[374],"J.":[379],"Chickering:":[380],"None.":[381,400],"M.":[382,388],"Cressman:":[383],"Covance,":[386],"LabCorp.":[387],"Currie:":[389],"G.T.":[398],"Milne:":[399],"A.T.":[401],"Profy:":[402],"Therapeutics,":[406,415],"Spouse/Partner;":[410],"UpToDate.":[411],"Funding":[418],"Therapeutics":[420]},"counts_by_year":[{"year":2020,"cited_by_count":1}],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2020-06-19T00:00:00"}